My account
Home
Push Notifications
Photo Gallery
EYE to EYE Las Vegas (Sept)
SECO 2026 >
SECO University >
Optometry News >
Archives >
Contact us
Important Info >
My Profile (optional)
Settings (clear caches)
ODCF
SECO International, LLC
July 21, 2026
ASRS 2026: Ixo-vec gene therapy sustains reduced anti-VEGF burden at 5 years in wet AMD
July 21, 2026
ASRS 2026: Pegcetacoplan shows greater treatment effect in eyes with GA and concurrent ...
July 21, 2026
GLP-1 RA Use Not Consistently Associated With Increased AMD Risk
July 21, 2026
ASRS 2026: Partial EZ attenuation predicts intermediate AMD progression | Eye Care Network
July 21, 2026
Delays Harmless for Most Macular Degeneration Patients - Medscape
July 21, 2026
Faricimab May Aid Hard-to-Treat Macular Degeneration Cases - Medscape
July 21, 2026
The clinical management of patients on antibody drug conjugates | Optometry Times
July 21, 2026
ASRS 2026: MCO-010 optogenetic therapy sustains 3-line vision gains at 3 years in retinitis ...
July 21, 2026
ASRS 2026: Nearly 40% of patients with wet AMD go untreated for 180 days within the first year
July 21, 2026
Future Treatment Strategies in Retinal Vascular Diseases | Eye Care Network - Ophthalmology Times
July 21, 2026
Can Oral Gildeuretinol Slow Advanced Macular Degeneration? - Conexiant
